» Articles » PMID: 39064298

Intersecting Pathways: The Role of Metabolic Dysregulation, Gastrointestinal Microbiome, and Inflammation in Acute Ischemic Stroke Pathogenesis and Outcomes

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Jul 27
PMID 39064298
Authors
Affiliations
Soon will be listed here.
Abstract

Acute ischemic stroke (AIS) remains a major cause of mortality and long-term disability worldwide, driven by complex and multifaceted etiological factors. Metabolic dysregulation, gastrointestinal microbiome alterations, and systemic inflammation are emerging as significant contributors to AIS pathogenesis. This review addresses the critical need to understand how these factors interact to influence AIS risk and outcomes. We aim to elucidate the roles of dysregulated adipokines in obesity, the impact of gut microbiota disruptions, and the neuroinflammatory cascade initiated by lipopolysaccharides (LPS) in AIS. Dysregulated adipokines in obesity exacerbate inflammatory responses, increasing AIS risk and severity. Disruptions in the gut microbiota and subsequent LPS-induced neuroinflammation further link systemic inflammation to AIS. Advances in neuroimaging and biomarker development have improved diagnostic precision. Here, we highlight the need for a multifaceted approach to AIS management, integrating metabolic, microbiota, and inflammatory insights. Potential therapeutic strategies targeting these pathways could significantly improve AIS prevention and treatment. Future research should focus on further elucidating these pathways and developing targeted interventions to mitigate the impacts of metabolic dysregulation, microbiome imbalances, and inflammation on AIS.

Citing Articles

Zebrafish navigating the metabolic maze: insights into human disease - assets, challenges and future implications.

Yashaswini C, Kiran N, Chatterjee A J Diabetes Metab Disord. 2024; 24(1):3.

PMID: 39697864 PMC: 11649609. DOI: 10.1007/s40200-024-01539-8.


Potential Mechanism and Perspectives of Mesenchymal Stem Cell Therapy for Ischemic Stroke: A Review.

Zhu P, Tan H, Gao H, Wang J, Liu Y, Yang D Glob Med Genet. 2024; 11(4):278-284.

PMID: 39224463 PMC: 11368559. DOI: 10.1055/s-0044-1790231.

References
1.
Kaura A, Sztriha L, Chan F, Aeron-Thomas J, Gall N, Piechowski-Jozwiak B . Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial. Eur J Med Res. 2019; 24(1):25. PMC: 6659210. DOI: 10.1186/s40001-019-0383-8. View

2.
Kim D, Howard A, Blanco E, Burrows R, Correa-Burrows P, Memili A . Dynamic relationships between body fat and circulating adipokine levels from adolescence to young adulthood: The Santiago Longitudinal Study. Nutr Metab Cardiovasc Dis. 2022; 32(4):1055-1063. PMC: 9107379. DOI: 10.1016/j.numecd.2022.01.001. View

3.
Zuniga L, Shen W, Joyce-Shaikh B, Pyatnova E, Richards A, Thom C . IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010; 185(11):6947-59. PMC: 3001125. DOI: 10.4049/jimmunol.1001269. View

4.
Levin S, Pershina E, Bugaev-Makarovskiy N, Chernomorets I, Konakov M, Arkhipov V . Why Do Levels Of Anti-inflammatory Cytokines Increase During Memory Acquisition?. Neuroscience. 2021; 473:159-169. DOI: 10.1016/j.neuroscience.2021.08.007. View

5.
Kruger-Genge A, Blocki A, Franke R, Jung F . Vascular Endothelial Cell Biology: An Update. Int J Mol Sci. 2019; 20(18). PMC: 6769656. DOI: 10.3390/ijms20184411. View